Abstract 1023: NOV C-ter: A novel preclinical anti-angiogenic agent

Junfeng Luo; Yong Teng; Minghui Li; Theodore S. Johnson; Franck Cuttitta; Zhengtao Chu; Xiaoyang Qi; John K. Cowell; Olivier Rixe

doi:10.1158/1538-7445.AM2014-1023

Abstract 1023: NOV C-ter: A novel preclinical anti-angiogenic agent

Junfeng Luo, Yong Teng, Minghui Li, Theodore S. Johnson, Franck Cuttitta, Zhengtao Chu, Xiaoyang Qi, John K. Cowell, Olivier Rixe

Research output: Contribution to conference › Paper › peer-review

Original language	English (US)
Pages	1023-1023
DOIs	https://doi.org/10.1158/1538-7445.AM2014-1023
State	Published - Oct 1 2014

Access to Document

10.1158/1538-7445.AM2014-1023

http://cancerres.aacrjournals.org/lookup/doi/10.1158/1538-7445.AM2014-1023

Cite this

@conference{387bb8d8b7c34db6a3b3fe6bf996c72b,

title = "Abstract 1023: NOV C-ter: A novel preclinical anti-angiogenic agent",

author = "Junfeng Luo and Yong Teng and Minghui Li and Johnson, {Theodore S.} and Franck Cuttitta and Zhengtao Chu and Xiaoyang Qi and Cowell, {John K.} and Olivier Rixe",

year = "2014",

month = oct,

day = "1",

doi = "10.1158/1538-7445.AM2014-1023",

language = "English (US)",

pages = "1023--1023",

}

TY - CONF

T1 - Abstract 1023: NOV C-ter: A novel preclinical anti-angiogenic agent

AU - Luo, Junfeng

AU - Teng, Yong

AU - Li, Minghui

AU - Johnson, Theodore S.

AU - Cuttitta, Franck

AU - Chu, Zhengtao

AU - Qi, Xiaoyang

AU - Cowell, John K.

AU - Rixe, Olivier

PY - 2014/10/1

Y1 - 2014/10/1

U2 - 10.1158/1538-7445.AM2014-1023

DO - 10.1158/1538-7445.AM2014-1023

M3 - Paper

SP - 1023

EP - 1023

ER -